In vitro screening, homology modeling and molecular docking studies of some pyrazole and imidazole derivatives.

A series of synthesized compounds based on pyrazole and imidazole skeletons prepared by palladium catalysts via a one-pot reaction was screened to determine their inhibitory potency against the pathogen fungus Fusarium oxysporum f.sp. albedinis (F.o.a) and four bacteria strains namely Micrococcus luteus, Bacillus subtilis, Staphylococcus aureus and Escherichia coli. The obtained result showed that these compounds exhibit an efficiency antifungal action. Whereas, they showed a very weak antibacterial activity. The structure-activity relationship (SAR) Analysis and lipophilicity study demonstrates the presence of a strong relation between the structure of the ligands and the antifungal activity. On the other hand, a homology modeling and molecular docking study was carried out on the most active compounds against F.o.a fungus, in order to understand and determine the molecular interactions taking place between the ligand and the corresponding receptor of the studied target.

[1]  V. Pliska,et al.  Lipophilicity: The Empirical Tool and the Fundamental Objective. An Introduction , 2008 .

[2]  P. Fossa,et al.  4-substituted 1,5-diarylpyrazole, analogues of celecoxib: synthesis and preliminary evaluation of biological properties. , 2003, Farmaco.

[3]  A. Hakkou,et al.  Antifungal activities of amino acid ester functional pyrazolyl compounds against Fusarium oxysporum f.sp. albedinis and Saccharomyces cerevisiae yeast , 2013 .

[4]  Thomas Lengauer,et al.  A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.

[5]  P. Liu,et al.  A new synthesis of pyrazoles through a Lewis acid catalyzed union of 3-ethoxycyclobutanones with monosubstituted hydrazines. , 2011, Organic letters.

[6]  Deepika Singh,et al.  Imidazole: Having Versatile Biological Activities , 2013 .

[7]  René Thomsen,et al.  MolDock: a new technique for high-accuracy molecular docking. , 2006, Journal of medicinal chemistry.

[8]  P. la Colla,et al.  Synthesis and antifungal properties of N-[(1,1'-biphenyl)-4-ylmethyl]-1H-imidazol-1-amine derivatives. , 2002, Farmaco.

[9]  Gisbert Schneider,et al.  Virtual screening and fast automated docking methods. , 2002, Drug discovery today.

[10]  S. Larran,et al.  Fusarium yellows of celery caused by fusarium oxysporum f. sp. APII in Argentina , 2008 .

[11]  B. Kim,et al.  Synthesis of novel 1,4,5-trisubstituted 3-trifluoromethylpyrazoles via microwave-assisted Stille coupling reactions , 2007 .

[12]  Jianpeng Ma,et al.  CHARMM: The biomolecular simulation program , 2009, J. Comput. Chem..

[13]  R. Touzani,et al.  Palladium-catalysed direct diarylations of pyrazoles with aryl bromides: a one step access to 4,5-diarylpyrazoles , 2014 .

[14]  C. Hansch,et al.  Structure-activity correlations for antibacterial agents on gram-positive and gram-negative cells. , 1968, Journal of medicinal chemistry.

[15]  C. L. Ventola.  The antibiotic resistance crisis: part 1: causes and threats. , 2015, P & T : a peer-reviewed journal for formulary management.

[16]  A. Shafiee,et al.  Design, synthesis, and biological evaluation of substituted 2-alkylthio-1,5-diarylimidazoles as selective COX-2 inhibitors. , 2007, Bioorganic & medicinal chemistry.

[17]  AtherFarooq Khan,et al.  Cross‐Coupling Reactions on Azoles with Two and More Heteroatoms , 2006 .

[18]  D. Davies,et al.  Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitor. , 1994, Biochemical pharmacology.

[19]  A. Mascarello,et al.  Relation between lipophilicity of alkyl gallates and antifungal activity against yeasts and filamentous fungi. , 2009, Bioorganic & medicinal chemistry letters.

[20]  A. Khalafi‐Nezhad,et al.  Synthesis of N-alkylated derivatives of imidazole as antibacterial agents. , 2003, Bioorganic & medicinal chemistry letters.

[21]  A. M. Vijesh,et al.  Synthesis, characterization and antimicrobial studies of some new pyrazole incorporated imidazole derivatives. , 2011, European journal of medicinal chemistry.

[22]  M. Bellaoui,et al.  New N,N,N',N'-tetradentate Pyrazoly Agents: Synthesis and Evaluation of their Antifungal and Antibacterial Activities. , 2016, Medicinal chemistry (Shariqah (United Arab Emirates)).

[23]  C. G. D. DE ALMEIDA,et al.  Relationship between structure and antibacterial activity of lipophilic N-acyldiamines. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[24]  J. Heitman,et al.  Signal Transduction Cascades Regulating Fungal Development and Virulence , 2000, Microbiology and Molecular Biology Reviews.

[25]  Ewelina Rutkowska,et al.  LIPOPHILICITY ñ METHODS OF DETERMINATION AND ITS ROLE IN MEDICINAL CHEMISTRY , 2012 .

[26]  G. G. Nascimento,et al.  Antibacterial activity of plant extracts and phytochemicals on antibiotic-resistant bacteria , 2000 .

[27]  R. Touzani,et al.  Pyrazole Derivatives with NCN Junction and their Biological Activity: AReview , 2016 .

[28]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[29]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[30]  R. Velazhahan,et al.  Mass production of Trichoderma harzianum for managing fusarium wilt of banana , 2004 .

[31]  N. Benhamou,et al.  Treatment with the Mycoparasite Pythium oligandrum Triggers Induction of Defense-Related Reactions in Tomato Roots When Challenged with Fusarium oxysporum f. sp. radicis-lycopersici. , 1997, Phytopathology.

[32]  Todd J. A. Ewing,et al.  DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases , 2001, J. Comput. Aided Mol. Des..

[33]  Aurélien Grosdidier,et al.  SwissDock, a protein-small molecule docking web service based on EADock DSS , 2011, Nucleic Acids Res..

[34]  Aurélien Grosdidier,et al.  Fast docking using the CHARMM force field with EADock DSS , 2011, J. Comput. Chem..

[35]  G. N. Sastry,et al.  Theoretical elucidation of the antioxidant mechanism of 1,3-dihydro-1-methyl-2H-imidazole-2-selenol (MSeI) , 2007 .

[36]  J. A. Vosloo,et al.  Antifungal peptides: To be or not to be membrane active. , 2016, Biochimie.

[37]  R. Henry,et al.  Synthesis of 4,5-diaryl-1H-pyrazole-3-ol derivatives as potential COX-2 inhibitors. , 2004, The Journal of organic chemistry.

[38]  V. Vijayakumar,et al.  Synthesis and antimicrobial activities of novel 1,5-diaryl pyrazoles. , 2010, European journal of medicinal chemistry.

[39]  M. Djerbi.  Diseases of the date palm (Phoenix dactylifera L.). , 1983 .

[40]  Maria Kontoyianni,et al.  Evaluation of docking performance: comparative data on docking algorithms. , 2004, Journal of medicinal chemistry.

[41]  S. Srivastava,et al.  FT-IR, HOMO-LUMO, NBO, MEP analysis and molecular docking study of 3-Methyl-4-{(E)-[4-(methylsulfanyl)-benzylidene]amino}1H-1,2,4-triazole-5(4H)-thione. , 2015, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[42]  Khaled R. A. Abdellatif,et al.  Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,3,5-triarylpyrazoline and 1,5-diarylpyrazole derivatives as selective COX-2 inhibitors. , 2016, Bioorganic & medicinal chemistry letters.

[43]  Urs Haberthür,et al.  FACTS: Fast analytical continuum treatment of solvation , 2008, J. Comput. Chem..

[44]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[45]  I. E. Hadrami,et al.  Effect of Arbuscular Mycorrhization on the Accumulation of Hydroxycinnamic Acid Derivatives in Date Palm Seedlings Challenged with Fusarium oxysporum f. sp. albedinis , 2008 .

[46]  S. Fustero,et al.  Recent Advances in the Synthesis of Pyrazoles. A Review , 2009 .

[47]  D. Higgins,et al.  Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega , 2011, Molecular systems biology.

[48]  S. Lahsasni,et al.  Antimicrobial/antioxidant activity and POM analyses of novel 7-o-β-d-glucopyranosyloxy-3-(4,5-disubstituted imidazol-2-yl)-4H-chromen-4-ones , 2015, Medicinal Chemistry Research.

[49]  Marco Biasini,et al.  SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information , 2014, Nucleic Acids Res..

[50]  B. Zaslavsky,et al.  Action of surface-active substances on biological membranes. IV. Hemolytic and membrane-perturbing action of homologous series of beta-D-glucopyranosyl-1-alkylphosphates. , 1979, Biochimica et biophysica acta.

[51]  S. Buchwald,et al.  An extremely active catalyst for the Negishi cross-coupling reaction. , 2004, Journal of the American Chemical Society.

[52]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[53]  Charles L. Wilson,et al.  Chitosan as a potential natural compound to control pre and postharvest diseases of horticultural commodities , 2006 .

[54]  Pedro Alexandrino Fernandes,et al.  Protein–ligand docking: Current status and future challenges , 2006, Proteins.

[55]  J. P. Harrity,et al.  Synthesis of ynone trifluoroborates toward functionalized pyrazoles. , 2012, Organic letters.

[56]  Richard B. Silverman,et al.  The Organic Chemistry of Drug Design and Drug Action , 1992 .

[57]  Randhir Singh,et al.  Imidazoles as promising scaffolds for antibacterial activity: a review. , 2013, Mini-Reviews in Medical Chemistry.

[58]  F. Ooms,et al.  Molecular modeling and computer aided drug design. Examples of their applications in medicinal chemistry. , 2000, Current medicinal chemistry.

[59]  S. Planey,et al.  The influence of lipophilicity in drug discovery and design , 2012, Expert opinion on drug discovery.

[60]  A. E. Hadrami,et al.  Chitosan, Antifungal Product against Fusarium oxysporum f. sp. albedinis and Elicitor of Defence Reactions in Date Palm Roots , 2004 .

[61]  A. Alam,et al.  Theoretical and experimental study on lipophilicity and wound healing activity of ginger compounds. , 2014, Asian Pacific journal of tropical biomedicine.

[62]  Francis O'Grady,et al.  ANTIBIOTIC AND CHEMOTHERAPY , 1974, The Ulster Medical Journal.

[63]  Cathy H. Wu,et al.  UniProt: the Universal Protein knowledgebase , 2004, Nucleic Acids Res..

[64]  A. Demain,et al.  Microbial drug discovery: 80 years of progress , 2009, The Journal of Antibiotics.

[65]  O. Feron,et al.  Library of synthetic compounds based on pyrazole unit: Design and screening against breast and colorectal cancer , 2014 .

[66]  Roman A. Laskowski,et al.  PDBsum: summaries and analyses of PDB structures , 2001, Nucleic Acids Res..

[67]  J. Bajorath,et al.  Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.

[68]  Byoung Ryong Jeong,et al.  Macromolecular Docking Simulation to Identify Binding Site of FGB1 for Antifungal Compounds , 2011 .

[69]  G. Schneider,et al.  Virtual Screening for Bioactive Molecules , 2000 .

[70]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[71]  F. Goldstein,et al.  Communiqué 1992 du comité de l'antibiogramme de la société française de microbiologie , 1990 .

[72]  C. Lipinski.  Lead- and drug-like compounds: the rule-of-five revolution. , 2004, Drug discovery today. Technologies.

[73]  N. Benchat,et al.  Synthesis, biological screening, POM, and 3D-QSAR analyses of some novel pyrazolic compounds , 2017, Medicinal Chemistry Research.